Home/Filings/4/0001180955-05-000063
4//SEC Filing

BENTLEY PHARMACEUTICALS INC 4

Accession 0001180955-05-000063

CIK 0000821616operating

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 8:10 PM ET

Size

17.4 KB

Accession

0001180955-05-000063

Insider Transaction Report

Form 4
Period: 2005-06-02
PRICE MICHAEL DENNIS
VP, CFO, Secretary & Treasurer
Transactions
  • Exercise/Conversion

    Common Stock, $.02 par value

    2005-06-02$4.73/sh+334$1,580267,202 total
  • Exercise/Conversion

    Common Stock, $.02 par value

    2005-06-02$2.89/sh+67,333$194,592133,535 total
  • Exercise/Conversion

    Right to purchase

    2005-06-02133,3330 total
    Exercise: $3.68From: 1999-12-10Exp: 2006-04-19Common Stock, $.02 par value (133,333 underlying)
  • Exercise/Conversion

    Right to purchase

    2005-06-02334133,000 total
    Exercise: $4.73From: 2000-01-06Exp: 2006-04-19Common Stock, $.02 par value (334 underlying)
  • Tax Payment

    Common Stock, $.02 par value

    2005-06-02$10.98/sh103,896$1,141,298163,306 total
  • Exercise/Conversion

    Common Stock, $.02 par value

    2005-06-02$3.68/sh+133,333$490,665266,868 total
  • Exercise/Conversion

    Right to purchase

    2005-06-0267,3330 total
    Exercise: $2.89From: 1996-06-12Exp: 2006-04-19Common Stock, $.02 par value (67,333 underlying)
Holdings
  • Common Stock, $.02 par value

    (indirect: By 401(k))
    7,181
Footnotes (2)
  • [F1]Represents previously-owned shares tendered to the Company to pay the option price for the above shares, and shares withheld by the Company (that were otherwise issuable upon exercise) to satisfy minimum federal tax withholding requirements in respect of the option exercises.
  • [F2]Options to purchase 400,000 shares of Common Stock were granted pursuant to terms approved by the Company's shareholders at the Annual Meeting of Shareholders on June 14, 1996. These options became exercisable in three equal installments on 6/12/96, 12/10/99 and 1/6/00 at exercise prices of $2.89, $3.68 and $4.73, respectively.

Issuer

BENTLEY PHARMACEUTICALS INC

CIK 0000821616

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000821616

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 8:10 PM ET
Size
17.4 KB